KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ)

$0.0132 -0.006875 (-34.2466%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 63

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) News Sources

Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome

24-06-2025

yahoo.com

Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy

15-07-2025

yahoo.com

KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) Sentiment Trend

0 25 50 75 100 68 58 24-06-2025 15-07-2025 #1 #2 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) FAQs

toggle

What is the current price of KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ)?

The current price of KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) is $0.0132.


toggle

KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) absolute price change since previous trading day?

The absolute price change of KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) since the previous trading day is $-0.006875.


toggle

KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) percentage price change since previous trading day?

The percentage price change of KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) since the previous trading day is -34.2466%.


toggle

What is the most recent average sentiment score for KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ)?

The most recent average sentiment score for KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) is 63 out of 100.


toggle

What is the most recent average sentiment for KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ)?

The most recent sentiment for KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ) is .


SEC-8K** Filing Available For KEEN VISION ACQUISITION C-28 (KVACW:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.